Life Sciences Archive » July, 2011

Life Sciences - July, 2011

165 articles

• Covidien Can't Evacuate FLSA Collective Action: Judge
• Fed. Circ. Affirms Lilly's Strattera Patent
• Judge Merges Shareholder Suits Over J&J FCPA Cases
• Fed. Circ. Rules Myriad Can Patent Breast Cancer Genes
• Pfizer Denied New Trial In $200M Neurontin MDL
• Allergan Hit With Off-Label Marketing FCA Suit
• FDA Should Scrap Moderate-Risk Review Process: Report
• J&J Cuts Maximum Tylenol Dose to Prevent Liver Damage
• Pfizer Hits Hetero With Suit Over Generic Viagra
• Pfizer, Others Not Liable For Gambling Addiction: 8th Circ.
• Pfizer Units Escape Suit Over Hormone Treatments
• Sen. Threatens To Hold Up FDA User Fee Renewal
• The Proper Care And Feeding Of Experts
• FDA Clarifies When Medical Device Changes Need Approval
• Ex-Taro Exec In Contempt Over $2M Insider Trading Fine
• AstraZeneca Settles Bulk Of Seroquel Diabetes Claims
• Medtronic Escapes Fraud Claims In Whistleblower Suit
• Fed. Circ. Won't Block Watson's Seasonique Generic
• Nelson Mullins Snags Pharma IP Expert
• Pfizer, Apotex To End Fight Over Generic Relpax
• AstraZeneca, Pozen Sue Lupin To Block Generic Vimovo
• ERX Incentive Program Changes — Too Little, Too Late?
• J&J Seeks Fed. Circ. Rehearing On Stent Patents
• Parsing Patent Term Extension In Europe
• Perrigo, Paddock Must Sell 6 Drugs In $540M Merger
• Pharma Cos. Fight Lilly Deposition Bid In Gemzar ITC Case
• DaVita Bilked Government For Wasted Kidney Drugs: Suit
• Astellas Stress Test Antitrust Suit Survives
• Trends In Qui Tam False Claims Cases
• Medco Investors Fight $29B Sale To Express Scripts
• CVS Pharmacists Denied Class Cert. In OT Action
• Judge Tosses Boehringer Workers' Wage-And-Hour Suit
• CDER Report Adds To New FDA Research Agenda
• Lupin, Medicis Reach Deal Over Generic Solodyn
• Obama Lays Out New Offensive Against Overseas Cartels
• Allos Investor Tries To Block $686M AMAG Merger
• Ky. Sues McKesson, First DataBank Over AWP Inflation
• Actos Needs Stronger Cancer Warnings: EU Regulator
• Synthes Targets Globus Over Spine Implant Patents
• Covington Reps Bristol-Myers In $325M Amira Buy
• 1st Circ. Revives FCA Claims In Amgen Kickback Suit
• $10M Suit Says Pfizer Failed To Warn Of Dilantin Effects
• Abbott Hits Hospira With Patent Suit Over Zemplar
• Great American Hits Pacific With Flood Coverage Suit
• Judge Swats Most Claims In Bug-Filled Similac Action
• FDA, EU Review Sanofi Heart Drug After Failed Trial
• InformedRx Sued Over Glucose Strip Expiration Dates
• Stiefel ERISA Plaintiffs Lose Class Cert. Bid
• Using The Anti-Injunction Act In Class Actions
• J&J Says Board Not To Blame For Recalls, Corruption Claims
• Bristol-Myers Settles AWP MDL Claims For $19M
• FTC Says Cardinal Health Must Sell Pharmacies
• Massey Sued By Respirator Co. In Black Lung Fight
• Fed. Circ. Says Teva Can't Block Cenestin Generic
• Novartis, Teva End Long-Running Lotrel Patent Suit
• Ropes & Gray Opens Shanghai Office
• Clear And Convincing Evidence In Invalidity Defense
• Medicis Seeks To Block Generic Loprox Shampoo
• Express Scripts' $29B Medco Buy To Face Antitrust Test
• Pay-For-Delay Ban Heads To Full Senate
• FDA Says Medical Device Reviews Must Be Streamlined
• Judge Pares Proskauer Tax Malpractice Suit
• Catalyst Sues Life Technologies Over DNA Sequencing IP
• Knobbe Martens Snags IP Atty For Silicon Valley Office
• Cooley, Latham Handle $686M AMAG-Allos Merger
• Using Consent Orders In Mass Tort Litigation
• Merck Fails To Nix Femina Birth Control Patent In ITC Row
• Ex-ArthroCare Exec Mostly Ducks $2.1M SEC Judgment
• Judge Tosses Deceptive Practices Claim In Seroquel Suit
• Zicam Inventor Admits Selling Unapproved Bird Flu Drug
• Aventis, Sun Settle Pair Of Allegra Generic Suits
• HGS Patent Suits Against Genentech Head To Calif.
• Improving The MSP Recovery Process
• False Marking Law Found Constitutional Again
• SEC Whistleblower Program Raises Privilege Worries
• NY Times Fires 1st In Webvention Data Patent Fight
• Lilly Again Sues APP Over Generic Alimta
• US Ends Prezista IP Suit Against Hetero Unit
• Ex-Rheingold Valet Partner Can Solicit Clients: Judge
• Hologic Triumphs In Mammogram Cushion IP Suit
• Suit Blames Diabetes Drug Byetta For Injuries, Deaths
• Q&A With Sheppard Mullin's Paul Garrity
• In Pursuit Of Individual Exclusions
• Amgen, Teva Settle Patent Suit Over Neopogen Generic
• General Dynamics Looks To Duck DataTern Patent Suit
• Shire Targets Mylan In Latest Suit Over Generic Vyvanse
• Bills Target OTC Drug Restriction On Health Accounts
• Skadden Reps Valeant In $345M Jannsen Unit Buy
• Contemplating Pliva V. Mensing
• Walgreen To Pay $3M Over Mass. Overbilling Claims
• Lupin Settles With Apotex Over Cholesterol Drug Patents
• Teva Drops Azilect Patent Claim Against Watson, Mylan
• Rite Aid Sues Ranbaxy Over Reglan Suit Indemnity
• Novartis Sales Reps File Suit Over Unpaid OT
• Orchid Shareholder Drops Suit Over $85M LabCorp Deal
• US Has No Immunity In Prezista Patent Case: Judge
• FDA Proposes Guidelines For Targeted Drug Therapies
• Judge Refuses To Toss Lead Counsel From Listerine MDL
• Tort Pro Joins Napoli Bern As Name Partner
• McDermott Nabs Ex-FTC Health Chief From Dechert
• Ill. Court Affirms $18M Verdict In Pain Patch Death
• Simpson Thacher Reps Apax In $6B Kinetic Concepts Deal
• FDA Warns Surgeons To Avoid Mesh Devices
• Ex-Nasdaq Exec Settles SEC Insider Trading Charges
• Boehringer Sales Rep Not Exempt From OT, Judge Says
• Prometheus: Bound For Clarification Or Confusion?
• Seattle Genetics Insider's Brother Pleads Guilty
• Biotronik Says CoStar Stent 'Recall' Violated Pact
• Astellas Settles Patent Suit Over Generic Adenoscan
• Winston Must Face Claims Over $56M Merger: Judge
• Braintree Ducks Indirect Purchasers' MiraLax Suit
• Reed Smith Opens In Shanghai With Dorsey Whitney Pro
• Edwards Angell Nabs MoFo IP Bigwig For NY Office
• Supreme Court Stacks Docket With IP Cases
• Translating India's New IT Law
• Feds Say Scios Mislabeled Heart Drug Natrecor
• Takeda, Mylan Reach Agreement Over Prevacid Generic
• Ex-Teva Scientist Testifies In Copaxone Patent Battle
• Perkins Coie Adds Patent Litigator in San Diego
• Medicare, Medicaid Sued Over Preferred Pharmacy Rule
• Nev. Court Won't Boot PDL BioPharma, Genentech Row
• High Court's IP Rulings In Rare Accord With Fed. Circ.
• Pfizer Targets Apotex In Fight To Block Generic Lyrica
• Jones Day Reps Sanofi In $425M Unit Sale To Valeant
• Purdue Targets Sandoz Over OxyContin Patents
• The Legal Duties Of Clinical Trial Sponsors
• Sandoz, Others Settle Medicaid Inflation MDL Suits
• Morgan Lewis Picks Up Jones Day Patent Pro
• Abbott Escapes Class Action Over Infested Similac
• Organon, Others Want $421M Medicaid FCA Suit Tossed
• Fed. Circ. Finds Respironics' Apnea Patents Invalid
• MarcTec Fights $5M Cordis Award In Fed. Circ.
• Fed. Circ. Overturns $5M RTI Win In Syringe IP Case
• Baker & McKenzie Adds Capital Pro In Beijing
• 4th Circ. Backs US In Medicaid Overbilling Row With W.Va.
• Watson Didn't Infringe Mucinex Patent: Fed. Circ.
• Teva Settles With Iowa In Wholesale Drug Suit
• Investor Hits BioMimetic With Fraud Action
• MiraLax Plaintiffs Win Injunction Against Braintree
• Wyeth Illegally Blocked Effexor XR Generics: Suit
• Don't Rock The Concord Boat
• J&J Suppressed Sales Of Cancer Test: Suit
• Pfizer Dodges More Sanctions In Neurontin Antitrust MDL
• Inyx Shareholders Win Class Cert. In Fraud Battle
• Shire Targets Roxane, Watson Over Generic Vyvanse
• DePuy, Calif. Co. Want Stryker Noncompete Deal Nixed
• FDA Bans Import Of Drugs From Dr. Reddy's Mexico Plant
• UK Court Favors Novartis In Lucentis Patent Suit
• Teva Asks Trial Judge To Dismiss Pfizer Viagra Suit
• Spotlight On Recent Preemption Decisions
• Boehringer Deal Leads EU Watchdog To Close Probe
• K&L Gates Adds Corporate Partners In Boston
• FDA Accuses Cadila Of Major Violations At India Plant
• EU Sees Drop In Pay-For-Delay Deals On Generics
• Barr Must Produce Docs In Provigil Pay-For-Delay Suit
• FDA Slams Zoll Over Defibrillator Battery Life Issues
• CareFusion To Pay $150M For Drug Dispenser Co. Rowa
• Actavis Settles Sanofi Suit Over Generic Allegra
• Study Ties Pfizer Anti-Smoking Drug To Heart Problems
• Ropes Reps TPG In $2B Bid To Take Immucor Private
• Shire Sues Sandoz, Amneal Over Vyvanse ANDA
• Ex-Stiefel Labs Exec Accuses Bosses Of $40M Con
• Depakote May Cause Cognitive Defects, FDA Warns
• Dog Owners Denied Class Cert. In ProMeris Suit
• A Bitter Pill For Brand Names?